Free Access
| Issue |
Med Sci (Paris)
Volume 29, Number 10, Octobre 2013
|
|
|---|---|---|
| Page(s) | 834 - 836 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/20132910007 | |
| Published online | 18 October 2013 | |
- Wesche J, Haglund K, Haugsten EM. Fibroblast growth factors and their receptors in cancer. Biochem J 2011 ; 437 : 199–213. [CrossRef] [PubMed] [Google Scholar]
- Beenken A, Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 2009 ; 8 : 235–253. [CrossRef] [PubMed] [Google Scholar]
- Daniele G, Corral J, Molife LR, de Bono JS. FGF receptor inhibitors: role in cancer therapy. Curr Oncol Rep 2012 ; 14 : 111–119. [CrossRef] [PubMed] [Google Scholar]
- McDermott LA, Simcox M, Higgins B, et al. RO4383596, an orally active KDR, FGFR, and PDGFR inhibitor: synthesis and biological evaluation. Bioorg Med Chem 2005 ; 13 : 4835–4841. [CrossRef] [PubMed] [Google Scholar]
- Chahrour O, Cairns D, Omran Z. Small molecule kinase inhibitors as anti-cancer therapeutics. Mini Rev Med Chem 2012 ; 12 : 399–411. [CrossRef] [PubMed] [Google Scholar]
- Conn PJ, Christopoulos A, Lindsley CW. Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nat Rev Drug Discov 2009 ; 8 : 41–54. [CrossRef] [PubMed] [Google Scholar]
- Thaker TM, Kaya AI, Preininger AM, et al. Allosteric mechanisms of G protein-coupled receptor signaling: a structural perspective. Methods Mol Biol 2012 ; 796 : 133–174. [CrossRef] [PubMed] [Google Scholar]
- Sebag JA, Pantel J. Ciblage thérapeutique des récepteurs couplés aux protéines G : la voie allostérique. Med Sci (Paris) 2012 ; 28 : 845–851. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Bono F, De Smet F, Herbert C, et al. Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties. Cancer Cell 2013 ; 23 : 477–488. [CrossRef] [PubMed] [Google Scholar]
- Herbert C, Schieborr U, Saxena K, et al. Molecular Mechanism of SSR128129E, an extracellularly acting, small-molecule, allosteric inhibitor of FGF receptor signaling. Cancer Cell 2013 ; 23 : 489–501. [CrossRef] [PubMed] [Google Scholar]
- Christopoulos A. Allosteric binding sites on cell-surface receptors: novel targets for drug discovery. Nat Rev Drug Discov 2002 ; 1 : 198–210. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.